P Glitz 15mg Tablet is prescribed for managing type 2 diabetes in adults. This medication effectively regulates blood glucose levels, helping to prevent serious diabetes-related complications such as kidney impairment and vision loss.
P Glitz 15mg Tablet can be used as monotherapy or in combination with other antidiabetic medications. It may be taken with or without meals. For optimal results, maintain a consistent daily dosing schedule. Your physician will determine the appropriate dosage, which may be adjusted periodically based on treatment response.
Continue this medication even if you feel well or achieve glycemic control. Discontinuing treatment without medical supervision may lead to elevated blood sugar levels, increasing risks of kidney damage, vision problems, neuropathy, and limb complications. This treatment should be combined with lifestyle modifications including a balanced diet, regular physical activity, and weight management as recommended by your healthcare provider.
Common adverse effects may include weight gain, visual disturbances, and paresthesia. Consult your doctor if these symptoms persist or cause concern.
This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe renal/hepatic impairment. Inform your physician about any history of cardiac conditions, thyroid disorders, or hormonal imbalances before starting treatment. Regular blood glucose monitoring and periodic liver function tests may be required during therapy.
THERAPEUTIC INDICATIONS
- Management of type 2 diabetes mellitus
THERAPEUTIC BENEFITS
Glycemic Control in Type 2 Diabetes
Effective glycemic management is crucial for preventing diabetes-related complications including nephropathy, retinopathy, neuropathy, and vascular disorders. When combined with recommended lifestyle modifications, this medication supports long-term metabolic health and quality of life.
ADVERSE EFFECTS
Frequently Reported Effects
- Increased body weight
- Visual disturbances
- Upper respiratory infections
- Peripheral neuropathy
- Increased fracture risk
ADMINISTRATION GUIDELINES
MECHANISM OF ACTION
Disclaimer:
Reviews
There are no reviews yet